MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients

MS4A6A has been recognized as being associated with aging and the onset of neurodegenerative disease. However, the mechanisms of MS4A6A in glioma biology and prognosis are ill-defined. Here, we show that MS4A6A is upregulated in glioma tissues, resulting in unfavorable clinical outcomes and poor res...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chunyu, Liu, Haitao, Tan, Yinqiu, Xu, Yang, Li, Yuntao, Tong, Shiao, Qiu, Sheng, Chen, Qianxue, Su, Zhongzhou, Tian, Daofeng, Zhou, Wei, Zhong, Chunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472524/
https://www.ncbi.nlm.nih.gov/pubmed/36119086
http://dx.doi.org/10.3389/fimmu.2022.865020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472524/
https://www.ncbi.nlm.nih.gov/pubmed/36119086
http://dx.doi.org/10.3389/fimmu.2022.865020

Ejemplares similares